These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1107 related articles for article (PubMed ID: 3000706)
21. Transforming growth factor production by chemically transformed cells. Moses HL; Branum EL; Proper JA; Robinson RA Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069 [TBL] [Abstract][Full Text] [Related]
22. A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone. Lau KH; Lee MY; Linkhart TA; Mohan S; Vermeiden J; Liu CC; Baylink DJ Biochim Biophys Acta; 1985 May; 840(1):56-68. PubMed ID: 2986710 [TBL] [Abstract][Full Text] [Related]
23. Production of transforming growth factors by simian sarcoma virus-transformed cells. van Zoelen EJ; van Rooijen MA; van Oostwaard TM; de Laat SW Cancer Res; 1987 Mar; 47(6):1582-7. PubMed ID: 3028611 [TBL] [Abstract][Full Text] [Related]
24. Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha. Myrdal SE; Twardzik DR; Auersperg N J Cell Biol; 1986 Apr; 102(4):1230-4. PubMed ID: 3007529 [TBL] [Abstract][Full Text] [Related]
25. A beta-type transforming growth factor, present in conditioned cell culture medium independent of cell transformation, may derive from serum. Stromberg K; Twardzik DR J Cell Biochem; 1985; 27(4):443-8. PubMed ID: 2987278 [TBL] [Abstract][Full Text] [Related]
26. Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. McGeady ML; Kerby S; Shankar V; Ciardiello F; Salomon D; Seidman M Oncogene; 1989 Nov; 4(11):1375-82. PubMed ID: 2812779 [TBL] [Abstract][Full Text] [Related]
27. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta. Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117 [TBL] [Abstract][Full Text] [Related]
28. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors. Game SM; Stone A; Scully C; Prime SS Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297 [TBL] [Abstract][Full Text] [Related]
29. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069 [TBL] [Abstract][Full Text] [Related]
30. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells. Newman MJ; Lane EA; Nugent MA; Racker E Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539 [TBL] [Abstract][Full Text] [Related]
31. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors. Chua CC; Geiman D; Ladda RL J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845 [TBL] [Abstract][Full Text] [Related]
32. Acidic cellular environments: activation of latent TGF-beta and sensitization of cellular responses to TGF-beta and EGF. Jullien P; Berg TM; Lawrence DA Int J Cancer; 1989 May; 43(5):886-91. PubMed ID: 2785508 [TBL] [Abstract][Full Text] [Related]
33. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Ignotz RA; Kelly B; Davis RJ; Massagué J Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6307-11. PubMed ID: 3018723 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells. Mooradian DL; Purchio AF; Furcht LT Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066 [TBL] [Abstract][Full Text] [Related]
35. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals. Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653 [TBL] [Abstract][Full Text] [Related]
36. Autonomous proliferation of MeWo human melanoma cell lines in serum-free medium: secretion of growth-stimulating activities. Sauvaigo S; Fretts RE; Riopelle RJ; Lagarde AE Int J Cancer; 1986 Jan; 37(1):123-32. PubMed ID: 3000950 [TBL] [Abstract][Full Text] [Related]
37. Behavior of transforming growth factors in serum-free media: an improved assay for transforming growth factors. Rizzino A In Vitro; 1984 Oct; 20(10):815-22. PubMed ID: 6335125 [TBL] [Abstract][Full Text] [Related]
38. [Growth factors produced by rat glioma cells: activities of transforming growth factors]. Kanno H; Shinonaga M; Kuwabara T; Umeda M No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559 [TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor (EGF)-nonresponsive variants of normal rat kidney cell line: response to EGF and transforming growth factor-beta. Hamanaka R; Ono M; Kuratomi Y; Mizoguchi H; Hirai R; Kohno K; Kuwano M Exp Cell Res; 1990 Jan; 186(1):83-9. PubMed ID: 2298239 [TBL] [Abstract][Full Text] [Related]